MYC and lymphoma: The present study shows that in double α1KI c-myc3′RR transgenic animals, the frequency of c-myc-driven tumors is decreased, their progression is lowered and the incurring lymphomas appear as more differentiated or even committed (in 10% of cases) into terminal BCR−, CD43+, CD138high plasma cell differentiation.